Literature DB >> 3893331

Increased in vivo secretory activity of neutrophil granulocytes in patients with psoriasis and palmoplantar pustulosis.

A Lundin, L Håkansson, R Hällgren, G Michaëlsson, P Venge.   

Abstract

The relationship between psoriasis and palmoplantar pustulosis (PPP) is uncertain, as is the role of the neutrophil granulocyte in these conditions. In a previous comparative study of the rate of polymorphonuclear leucocyte (PMN) phagocytosis of IgG- and IgG-C3b-coated particles, an increased uptake rate was found in both diseases. Further information on the in vivo activity of PMNs in these conditions may be obtainable by determining the level of lactoferrin (LF) in serum from such patients, since LF serves as a specific marker of the turnover and activity of the circulating pool of neutrophils. In this study on 19 patients with psoriasis and 20 patients with PPP, elevated levels of LF were found in both conditions. In contrast, the levels of lysozyme and beta 2-microglobulin, which are markers of monocyte-macrophage and lymphocyte activity, respectively, were normal. This suggests the selective activation of neutrophils in these disorders. LF was significantly correlated (P less than 0.05 and 0.001, respectively) to the rates of phagocytosis of IgG- and IgG-C3b-coated particles, but not to the chemotaxis of isolated PMNs. There was no correlation between the severity of the disease and the levels of serum LF. The data suggest the increased in vivo activity of neutrophils in psoriasis and PPP.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3893331     DOI: 10.1007/bf00404313

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  25 in total

1.  Identification of a serum-derived promotor of granulocyte granule secretion: study on a patient with chronic pruritus.

Authors:  P Venge; M Boberg; L Håkansson; C Peterson
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

2.  Enhanced release of inflammatory mediators from lithium-stimulated neutrophils in psoriasis.

Authors:  F J Bloomfield; M M Young
Journal:  Br J Dermatol       Date:  1983-07       Impact factor: 9.302

3.  Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway.

Authors:  E F Plow
Journal:  J Clin Invest       Date:  1982-03       Impact factor: 14.808

4.  Induction of fibrin thrombi by monocytes.

Authors:  W B Shelley; L Juhlin
Journal:  Nature       Date:  1977-11-24       Impact factor: 49.962

5.  Plasma myeloperoxidase and lactoferrin measured by radioimmunoassay: relations to neutrophil kinetics.

Authors:  N E Hansen; J Malmquist; J Thorell
Journal:  Acta Med Scand       Date:  1975-12

6.  Effects of serum and cations on the selective release of granular proteins from human netrophils during phagocytosis.

Authors:  P Venge; R Hällgren; G Stålenheim; I Olsson
Journal:  Scand J Haematol       Date:  1979-04-04

7.  Increased granulocyte adherence in psoriasis and psoriatic arthritis.

Authors:  J B Sedgwick; P R Bergstresser; E R Hurd
Journal:  J Invest Dermatol       Date:  1980-02       Impact factor: 8.551

8.  Altered polymorphonuclear leukocyte responses in psoriasis: chemotaxis and degranulation.

Authors:  W C Preissner; J M Schröder; E Christophers
Journal:  Br J Dermatol       Date:  1983-07       Impact factor: 9.302

9.  Neutropenia induced by systemic infusion of lactoferrin.

Authors:  L A Boxer; B Björkstén; J Björk; H H Yang; J M Allen; R L Baehner
Journal:  J Lab Clin Med       Date:  1982-06

10.  Lactoferrin: a promoter of polymorphonuclear leukocyte adhesiveness.

Authors:  R Oseas; H H Yang; R L Baehner; L A Boxer
Journal:  Blood       Date:  1981-05       Impact factor: 22.113

View more
  3 in total

1.  Neutrophil locomotion and serum chemotactic and chemokinetic activities in pustulosis palmoplantaris compared with psoriasis.

Authors:  A Lundin; L Håkansson; G Michaëlsson; P Venge
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

2.  Etretinate or cyclosporin-A treatment normalizes the enhanced respiratory burst of polymorphonuclear leukocytes in psoriasis.

Authors:  R E Schopf; J Höcher; M Rehder; L Färber; B Morsches
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

3.  Contribution of myeloperoxidase and inducible nitric oxide synthase to pathogenesis of psoriasis.

Authors:  Nursel Dilek; Aziz Ramazan Dilek; Yakup Taşkın; Taşkın Erkinüresin; Ömer Yalçın; Yunus Saral
Journal:  Postepy Dermatol Alergol       Date:  2016-12-02       Impact factor: 1.837

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.